Kampala, April 14, 2025 – The United States has strengthened Uganda's response to the Ebola outbreak by donating 100 vials of monoclonal antibodies to the Uganda Ministry of Health. These antibodies, which potentially improve survival rates for Ebola patients, are part of ongoing efforts to tackle the Sudan Ebola Virus (SUDV) outbreak in the country.
At the National Medical Stores, U.S. Ambassador William W. Popp presented the treatments to Uganda's State Minister for Health, General Duties, Anifa Kawooya Bangirana. The treatments will be stored safely for future use, effective for years under proper conditions. During the 2022 outbreak, similar donations were made to manage the SUDV outbreak successfully in Mubende.
“The United States’ donation of monoclonal antibodies is an important contribution to the global fight against Ebola, saving lives in Uganda, and making both America and Uganda safer,” said Ambassador Popp. “Providing these groundbreaking treatments demonstrates the United States’ strong commitment to innovation, scientific excellence, shared prosperity, and global health security," he added.
This therapy is part of broader U.S. assistance, supplementing more than $6 million already committed to Uganda’s 2025 Ebola response. These funds support various activities, including case identification, surveillance, contact tracing, lab diagnostics, screening, public messaging, community outreach, and infection prevention. This support underlines the U.S. government's dedication to enhancing Uganda's health system and responding to health threats that aim to protect both nations.
For further information, inquiries can be directed to KampalaPress@state.gov.